Stevens Capital Management LP Pacific Biosciences Of California, Inc. Transaction History

Stevens Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$4.99 - $6.16 $61,726 - $76,199	-12,370 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$5.92 - $7.41 $310,504 - $388,654	-52,450 Reduced 80.92%	12,370 $75,000
Q1 2019 May 03, 2019	SELL	$6.8 - $7.4 $1.83 Million - $2 Million	-269,783 Reduced 80.63%	64,820 $469,000
Q4 2018 Feb 06, 2019	BUY	$3.99 - $7.82 $1.34 Million - $2.62 Million	334,603 New	334,603 $2.48 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.